Dutch gene therapy company uniQure N.V. on wednesday announced the pricing of its underwritten public offering of 5,000,000 of its ordinary shares at a public offering price of $18.25 per share.
UniQure said it expects to get $91,250,000 from the offering.
The company added that all ordinary shares to be sold in the offering are being sold by uniQure.